SCHEMBL26322741

SCHEMBL26322741

Cc1cc(Nc2ccnc(NC(=O)c3ccc(N)cc3)c2)ccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.53
▸ MAPT P10636 1/20 0.53
▸ NPC1 O15118 6/20 0.49
▸ RAB9A P51151 6/20 0.49
▸ HDAC3 O15379 1/20 0.49
▸ HDAC1 Q13547 1/20 0.49
▸ HDAC2 Q92769 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ PKM P14618 2/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ APEX1 P27695 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ JAK2 O60674 1/20 0.45
▸ TYK2 P29597 1/20 0.45
▸ DNMT1 P26358 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23999527 0.90 POLB (0.68) POLBMAPTNPC1RAB9AHDAC3
SCHEMBL23999498 0.89 MAPT (0.51) POLBMAPTNPC1RAB9AHDAC3
SCHEMBL24004057 0.87 ABL1 (0.57) POLBMAPTHDAC3HDAC1HDAC2
SCHEMBL24004060 0.86 POLB (0.72) POLBMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL24010909 0.86 BRAF (0.53) MAPTNPC1RAB9AHDAC3HDAC1
SCHEMBL26322770 0.85 MAPK8 (0.48) HDAC3HDAC1HDAC2HDAC6KMT2A
SCHEMBL23999635 0.82 POLB (0.56) POLBMAPTNPC1RAB9AHDAC3
SCHEMBL23999624 0.78 MAPT (0.63) POLBMAPTHDAC3HDAC1HDAC2
SCHEMBL23999629 0.78 MAPT (0.63) POLBMAPTHDAC3HDAC1HDAC2
SCHEMBL23999529 0.78 RAD52 (0.57) POLBMAPTNPC1RAB9AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR POLB 2552/4885MAPT 3962/4885NPC1 1106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback